Please login to the form below

Not currently logged in
Email:
Password:

Data

This page shows the latest Data news and features for those working in and with pharma, biotech and healthcare.

Biogen and Eisai drop Alzheimer’s drug elenbecestat

Biogen and Eisai drop Alzheimer’s drug elenbecestat

Data Safety Monitory Board suggested the drug had an “unfavourable risk-benefit ratio”. . ... Lynn Kramer, chief clinical officer, Neurology Business Group, Eisai. “We are very disappointed with the news, and intend to learn from these data and

Latest news

More from news
Approximately 127 fully matching, plus 7,486 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 46 fully matching, plus 1,013 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 1,005 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 66 fully matching, plus 562 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics